Kaya Holdings (KAYS) Other Non-Current Assets (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Other Non-Current Assets of $7886.0 in Q3 2025, up 12.88% quarter-over-quarter from $6986.0 in Q2 2025, and down 73.32% on a YoY basis from $29553.0 in Q3 2024.
Kaya Holdings (KAYS) Other Non-Current Assets (2011 - 2025) Analysis & Trends
Kaya Holdings' Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $7886.0 for Q3 2025.
- In Q3 2025, Other Non-Current Assets fell 73.32% year-over-year to $7886.0; the TTM figure through Sep 2025 stood at $7886.0 (down 73.32% YoY), while the FY2024 annual figure was $28771.0, down 28.92% from the prior year.
- Other Non-Current Assets was $7886.0 for Q3 2025 at Kaya Holdings, up from $6986.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $96986.0 in Q1 2022 to a low of $5491.0 in Q2 2023.
- Historically, Other Non-Current Assets has averaged $38045.0 across 5 years, with a median of $28771.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 1369.41% in 2022, then tumbled 94.08% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $82159.0 in 2021, then slumped by 66.92% to $27175.0 in 2022, then jumped by 48.96% to $40479.0 in 2023, then slipped by 28.92% to $28771.0 in 2024, then tumbled by 72.59% to $7886.0 in 2025.
- The last three Other Non-Current Assets figures came in at $7886.0 (Q3 2025), $6986.0 (Q2 2025), and $29232.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Kaya Holdings | - | - | 5,370.00 | 7,886.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7,886.00 |
| Jun 30, 2025 | 6,986.00 |
| Mar 31, 2025 | 29,232.00 |
| Dec 31, 2024 | 28,771.00 |
| Sep 30, 2024 | 29,553.00 |
| Jun 30, 2024 | 5,491.00 |
| Mar 31, 2024 | 5,491.00 |
| Dec 31, 2023 | 40,479.00 |
| Sep 30, 2023 | 40,005.00 |
| Jun 30, 2023 | 5,491.00 |
| Mar 31, 2023 | 27,349.00 |
| Dec 31, 2022 | 27,175.00 |
| Sep 30, 2022 | 91,706.00 |
| Jun 30, 2022 | 92,760.00 |
| Mar 31, 2022 | 96,986.00 |
| Dec 31, 2021 | 82,159.00 |
| Sep 30, 2021 | 6,241.00 |
| Jun 30, 2021 | 82,587.00 |
| Mar 31, 2021 | 16,507.00 |
| Dec 31, 2020 | 16,507.00 |